The City’s biotech industry got a boost Tuesday, as Mayor Ed Lee joined the Canadian ambassador to the United States in announcing a new startup incubator in UCSF’s growing hub for such companies.
CTA@MissionBay will focus on Canadian life sciences firms and join four other UCSF incubators involved in the California Institute for Quantitative Biosciences, or QB3. In what has become standard fare for news of economic expansion, the mayor said the development is further evidence that San Francisco is the “innovation capital of the world.”
With the introduction of a Canadian partner, UCSF is drawing its own unique comparison.
“Mission Bay has established itself as a world center for bioscience entrepreneurs,” Regis Kelly, director of QB3, said in a statement. “These new companies join a community that is rapidly becoming a United Nations of innovation.”
Lee lauded his predecessors, mayors Gavin Newsom and Willie Brown, for spurring redevelopment of the Mission Bay section of The City. San Francisco now houses 108 life sciences companies — up from just two in 2004 — according to a press release from the Mayor’s Office.
Pharmaceutical and health care research technology companies involved in the new incubator include Aquinox, BioMark, Clinisys, and Precision Nanosystems.